New York City health officials say more than 200 patients with cancer are in stable condition after being treated in biofit scrubbed room

NEW YORK — More than 200 people with cancer have been stabilized in a biofit room in a Brooklyn hospital after they were treated in a facility that is the brainchild of New York Mayor Bill de Blasio.

“I’m pleased to report that many of our patients are in excellent condition,” said Dr. Jennifer Smith, the New York Health Department’s chief medical officer.

“It’s important to note that we’re dealing with a patient population of the highest quality and we’re seeing a great recovery rate.

But as with any patient, you don’t know for sure until we can see the actual patient.”

De Blasio announced plans to open the BioFit Cleanroom and Salon in Brooklyn in December, and it was a huge boost to the health department.

It is a small, private facility that uses a different cleaning system than many hospitals, including the one that has been used in Los Angeles for years.

Biofit Cleanroom chairs are made of plastic, and there are two different cleaning systems in the room, but Smith said the biofit cleaners were “a really nice way to get people back in the house.”

She said the program is a collaboration between the department and a nonprofit that promotes cleanliness in New York and across the United States.

The program includes several different cleaning options, including a biofitter that uses the BioFIT system, a machine that cleans surfaces and uses water.

It also uses a biofeedback device, a device that mimics a natural environment.

Smith said the company has hired about 15 people, including staff from BioFit, and the facility is expected to open this summer.

The BioFit Salon also will offer a variety of cleaning services to patients, including cleaning up after their pets and cleaning their homes, Smith said.

The city has also invested in biofittings in several other locations, including in Brooklyn, where the Bio-FIT Center is located.

The city is also partnering with the Biotechnology Institute of America in developing a biofits program that will help treat patients.